Home/Pipeline/Posaconazole DR Tablets

Posaconazole DR Tablets

Fungal Infection

ApprovedActive

Key Facts

Indication
Fungal Infection
Phase
Approved
Status
Active
Company

About i3 Pharmaceuticals

i3 Pharmaceuticals is a specialty generic drug company founded by industry veterans to address high-barrier, complex solid oral dosage forms. The company's strategy centers on applying deep technical know-how to develop and manufacture generics for poorly soluble, unstable, or potent compounds, with a fully integrated US-based facility for development through commercial supply. Since its operational launch, i3 has successfully passed FDA inspections and commercialized several products, positioning itself in the niche but valuable market for technically challenging generics.

View full company profile

Other Fungal Infection Drugs

DrugCompanyPhase
BioCode Fungal PanelApplied BioCodeResearch